The "-OMICS" facet of melanoma: Heterogeneity of genomic, proteomic and metabolomic biomarkers.

Donnelly, Douglas; Aung, Phyu P; Jour, George

Donnelly, Douglas; Aung, Phyu P; Jour, George.

Afiliação

Donnelly D; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, United States; Interdisciplinary Melanoma Program, New York University School of Medicine, New York, NY, United States.
Aung PP; Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Jour G; The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, NY, United States; Interdisciplinary Melanoma Program, New York University School of Medicine, New York, NY, United States; Department of Pathology, New York University School of Medicine, New York, NY, United States. Electronic address: George.jour@nyumc.org.

Semin Cancer Biol ; 59: 165-174, 2019 12.

Article em En | MEDLINE | ID: mdl-31295564

Assuntos

Biomarcadores Tumorais; Genômica; Melanoma/etiologia; Melanoma/metabolismo; Metabolômica; Proteômica; Biomarcadores; Ácidos Nucleicos Livres; Epigênese Genética; Genômica/métodos; Humanos; Melanoma/diagnóstico; Metabolômica/métodos; Prognóstico; Proteômica/métodos; Microambiente Tumoral

Palavras-chave

Epigenetic biomarker; Melanoma; Metabolomics; Proteomics; Serum biomarker; mir-RNA

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Genômica / Proteômica / Metabolômica / Melanoma Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google